HAL (France)
open access
Expression of Versican Isoform V3 in the Absence of Ascorbate Improves Elastogenesis in Engineered Vascular Constructs
Since Scribner described the first prosthetic chronic dialysis shunt in 1961, the surgical techniques and strategies to maintain vascular access have improved dramatically. Today, hundreds of thousands of patients worldwide are treated with some combination of native vein fistula, synthetic vascular
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-term results of autologous scaffold-free tissue-engineered vascular graft for hemodialysis access#1358526
- Reducing Hemodialysis Catheter Use in Prevalent Hemodialysis Patients#845214
- Scaffold for Regenerative Organization of Prosthetic Organ Tissue and Method — Vactronix Scientific, Llc (US20220370185A1)#607620
- Evaluation of Heparin Bonded Vascular Graft Versus Standard Graft in Prosthetic Arteriovenous Access for Hemodialysis#1075721
- Stent biomechanics in hemodialysis-related left brachiocephalic vein stenosis: from site-specific loading to a staged device-validation framework.#1367933
Record · ID 1345612
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive